These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27348355)

  • 1. Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth.
    Pérez-Pérez MJ; Priego EM; Bueno O; Martins MS; Canela MD; Liekens S
    J Med Chem; 2016 Oct; 59(19):8685-8711. PubMed ID: 27348355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in the study of the anti-tumor activity of small molecule vascular disrupting agents].
    Cai YC; Zou Y; Xian LJ
    Yao Xue Xue Bao; 2010 Mar; 45(3):283-8. PubMed ID: 21351502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New oxazole-bridged combretastatin A-4 analogues as potential vascular-disrupting agents.
    Mahal K; Biersack B; Schobert R
    Int J Clin Pharmacol Ther; 2013 Jan; 51(1):41-3. PubMed ID: 23259996
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in vascular disrupting agents in cancer therapy.
    Porcù E; Bortolozzi R; Basso G; Viola G
    Future Med Chem; 2014 Sep; 6(13):1485-98. PubMed ID: 25365233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vascular disrupting agent STA-9584 exhibits potent antitumor activity by selectively targeting microvasculature at both the center and periphery of tumors.
    Foley KP; Zhou D; Borella C; Wu Y; Zhang M; Jiang J; Li H; Sang J; Korbut T; Ye J; Zhang X; Barsoum J; Sonderfan AJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):529-38. PubMed ID: 22837008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disrupting tumour blood vessels.
    Tozer GM; Kanthou C; Baguley BC
    Nat Rev Cancer; 2005 Jun; 5(6):423-35. PubMed ID: 15928673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubulin colchicine binding site inhibitors as vascular disrupting agents in clinical developments.
    Ji YT; Liu YN; Liu ZP
    Curr Med Chem; 2015; 22(11):1348-60. PubMed ID: 25620094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combretastatin-based compounds with therapeutic characteristics: a patent review.
    Nainwal LM; Alam MM; Shaquiquzzaman M; Marella A; Kamal A
    Expert Opin Ther Pat; 2019 Sep; 29(9):703-731. PubMed ID: 31369715
    [No Abstract]   [Full Text] [Related]  

  • 9. Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis.
    Banerjee S; Hwang DJ; Li W; Miller DD
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27827858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies.
    Kanthou C; Tozer GM
    Int J Exp Pathol; 2009 Jun; 90(3):284-94. PubMed ID: 19563611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and hit to lead optimization of novel combretastatin A-4 analogues: dependence of C-linker length and hybridization.
    Provot O; Hamze A; Peyrat JF; Brion JD; Alami M
    Anticancer Agents Med Chem; 2013 Dec; 13(10):1614-35. PubMed ID: 24261611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo and Mechanistic Studies on Antitumor Lead 7-Methoxy-4-(2-methylquinazolin-4-yl)-3,4-dihydroquinoxalin-2(1H)-one and Its Modification as a Novel Class of Tubulin-Binding Tumor-Vascular Disrupting Agents.
    Cui MT; Jiang L; Goto M; Hsu PL; Li L; Zhang Q; Wei L; Yuan SJ; Hamel E; Morris-Natschke SL; Lee KH; Xie L
    J Med Chem; 2017 Jul; 60(13):5586-5598. PubMed ID: 28653846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of the combretastatins as tumour vascular targeting agents.
    Tozer GM; Kanthou C; Parkins CS; Hill SA
    Int J Exp Pathol; 2002 Feb; 83(1):21-38. PubMed ID: 12059907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Starvation tactics for solid tumors: tumor blood flow interruption via a combretastatin derivative (Cderiv), and its microcirculation mechanism.
    Hori K
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):109-22. PubMed ID: 22101805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antivascular and antitumor properties of the tubulin-binding chalcone TUB091.
    Canela MD; Noppen S; Bueno O; Prota AE; Bargsten K; Sáez-Calvo G; Jimeno ML; Benkheil M; Ribatti D; Velázquez S; Camarasa MJ; Díaz JF; Steinmetz MO; Priego EM; Pérez-Pérez MJ; Liekens S
    Oncotarget; 2017 Feb; 8(9):14325-14342. PubMed ID: 27224920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current development status of small-molecule vascular disrupting agents.
    Chaplin DJ; Horsman MR; Siemann DW
    Curr Opin Investig Drugs; 2006 Jun; 7(6):522-8. PubMed ID: 16784022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro model that can distinguish between effects on angiogenesis and on established vasculature: actions of TNP-470, marimastat and the tubulin-binding agent Ang-510.
    van Wijngaarden J; Snoeks TJ; van Beek E; Bloys H; Kaijzel EL; van Hinsbergh VW; Löwik CW
    Biochem Biophys Res Commun; 2010 Jan; 391(2):1161-5. PubMed ID: 20004648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazole Analogs of Vascular-Disrupting Combretastatin A-4 with Pleiotropic Efficacy against Resistant Colorectal Cancer Models.
    Reipsch F; Biersack B; Lucas H; Schobert R; Mueller T
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AVE8062: a new combretastatin derivative vascular disrupting agent.
    Delmonte A; Sessa C
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1541-8. PubMed ID: 19758109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ; Sriram M; Strecker TE; Tidmore JK; Jelinek CJ; Kumar GD; Hadimani MB; Pettit GR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5146-9. PubMed ID: 18710804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.